Cargando…
Intraoperative delivery of the Notch ligand Jagged-1 regenerates appendicular and craniofacial bone defects
Each year, 33% of US citizens suffer from a musculoskeletal condition that requires medical intervention, with direct medical costs approaching $1 trillion USD per year. Despite the ubiquity of skeletal dysfunction, there are currently limited safe and efficacious bone growth factors in clinical use...
Autores principales: | Youngstrom, Daniel W., Senos, Rafael, Zondervan, Robert L., Brodeur, Jack D., Lints, Austin R., Young, Devin R., Mitchell, Troy L., Moore, Megan E., Myers, Marc H., Tseng, Wei-Ju, Loomes, Kathleen M., Hankenson, Kurt D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732299/ https://www.ncbi.nlm.nih.gov/pubmed/29302365 http://dx.doi.org/10.1038/s41536-017-0037-9 |
Ejemplares similares
-
Jagged1 expression by osteoblast-lineage cells regulates trabecular bone mass and periosteal expansion in mice
por: Youngstrom, D.W., et al.
Publicado: (2016) -
NOTCH ligands JAG1 and JAG2 as critical pro-survival factors in childhood medulloblastoma
por: Fiaschetti, Giulio, et al.
Publicado: (2014) -
JAG1-NOTCH4 mechanosensing drives atherosclerosis
por: Souilhol, Celine, et al.
Publicado: (2022) -
Notch3/Jagged1 Circuitry Reinforces Notch Signaling and Sustains T-ALL()()
por: Pelullo, Maria, et al.
Publicado: (2014) -
The Notch Ligand Jagged1 as a Target for Anti-Tumor Therapy
por: Li, Demin, et al.
Publicado: (2014)